Clinical Trial Update: CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease [Phase 3]

View source ↗

Summary

Phase 3 CASPAR trial evaluated clopidogrel plus aspirin in bypass surgery for peripheral arterial disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Sanofi | Conditions: Arterial Occlusive Diseases | Phase 3 | Status: COMPLETED